International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
International Journal of Celiac Disease. 2017, 5(3), 111-114
DOI: 10.12691/ijcd-5-3-2
Open AccessArticle

Inpatient Hospital Costs for Celiac Disease in the United States in 2014

Eric P. Borrelli1,

1University of Rhode Island, College of Pharmacy, Kingston, Rhode Island, United States

Pub. Date: August 08, 2017

Cite this paper:
Eric P. Borrelli. Inpatient Hospital Costs for Celiac Disease in the United States in 2014. International Journal of Celiac Disease. 2017; 5(3):111-114. doi: 10.12691/ijcd-5-3-2


Celiac disease (CD) is a rare autoimmune disease that affects approximately 0.5 to1% of the United States (U.S.) population. Patients with CD have gastrointestinal disturbances resulting from eating gluten. The only treatment therapy available is maintaining a strict gluten free diet. Currently, there is not much published data detailing the direct cost of CD in the U.S. This study analyzed direct inpatient hospitalization costs of CD in the U.S. The Healthcare Cost and Utilization Project net (HCUPnet) was analyzed to determine the number of discharges, mean length of stay, mean cost per hospitalization, and total expenditures of several patient demographics in the U.S. for the year 2014. There were 805 discharges in 2014 in the U.S. The mean cost per hospitalization was $9,247 (SD $17,732) and the mean length of stay was 4.9 days. The aggregate cost of celiac in the in 2014 was $7,413,355 (SD $23,320,823). Different patient demographics resulted in variable costs and length of stay for patients. The mean cost of hospitalization for CD was lower than that of the general population in the across all disease states. With no approved cures or treatment, CD will contribute to health expenditures in the U.S. for the foreseeable future.

celiac disease cost health economics epidemiology

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the . Am J Gastroenterol. 2012 Oct; 107(10): 1538-44
[2]  Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003 Feb 10; 163(3): 286-92.
[3]  Dubé C, Rostom A, Sy R, Cranney A, Saloojee N, Garritty C, Sampson M, Zhang L, Yazdi F, Mamaladze V, Pan I, Macneil J, Mack D, Patel D, Moher D. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005 Apr; 128(4 Suppl 1): S57-67.
[4]  Gujral N, Freeman HJ, Thomson AB. Celiac disease: Prevalence, diagnosis, pathogenesis and treatment. World Journal of Gastroenterology: WJG. 2012; 18(42): 6036-6059.
[5]  Perera DR, Weinstein WM, Rubin CE. Symposium on pathology of the gastrointestinal tract-Part II. Small intestinal biopsy. Hum Pathol. 1975 Mar; 6(2):157-217.
[6]  Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’) Gastroenterology. 1992; 102: 330-354.
[7]  Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999; 11: 1185-1194.
[8]  Rostami K, Mulder CJ, Werre JM, van Beukelen FR, Kerchhaert J, Crusius JB, Peña AS, Willekens FL, Meijer JW. High prevalence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch population. Scand J Gastroenterol. 1999; 34: 276-279.
[9]  Rampertab SD, Pooran N, Brar P, Singh P, Green PH. Trends in the presentation of celiac disease. Am J Med. 2006; 119: 355. e9-355.14.
[10]  Rubio-Tapia A, Van Dyke CT, Lahr BD, Zinsmeister AR, El-Youssef M, Moore SB, Bowman M, Burgart LJ, Melton LJ, 3rd, Murray JA. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol. 2008; 6: 983-7.
[11]  Book L, Zone JJ, Neuhausen SL. Prevalence of celiac disease among relatives of sib pairs with celiac disease in U.S. families. Am J Gastroenterol. 2003 Feb; 98(2): 377-81.
[12]  Esmaeilzadeh A, Ganji A, Goshayeshi L, Ghafarzadegan K, Afzal Aghayee M, Mosanen Mozafari H, Saadatniya H, Hayatbakhs A, Ghavami Ghanbarabadi V. Adult Celiac Disease: Patients Are Shorter Compared with Their Peers in the General Population. Middle East J Dig Dis. 2016 Oct; 8(4): 303-309.
[13]  Cosnes J, Cosnes C, Cosnes A, Contou JF, Reijasse D, Carbonnel F, Beaugerie L, Gendre JP. [Undiagnosed celiac disease in childhood]. Gastroenterol Clin Biol. 2002 Jun-Jul; 26(6-7): 616-23.
[14]  Shah S, Leffler D. Celiac disease: an underappreciated issue in women’s health. Womens Health (Lond). 2010 Sep; 6(5): 753-66.
[15]  Megiorni F, Mora B, Bonamico M, Barbato M, Montuori M, Viola F, Trabace S, Mazzilli MC. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol. 2008 Apr; 103(4): 997-1003.
[16]  Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, Mcmahon DJ, Absan H, Neugut AI. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001 Jan; 96(1): 126-31.
[17]  Chou R, Bougatsos C, Blazina I, Mackey K, Grusing S, Selph S. Screening for Celiac Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2017 Mar 28; 317(12): 1258-1268.
[18]  Violato M, Gray A, Papanicolas I, Ouellet M. Resource Use and Costs Associated with Coeliac Disease before and after Diagnosis in 3,646 Cases: Results of a UK Primary Care Database Analysis. Singh SR, ed. PLoS ONE. 2012; 7(7): e41308.
[19]  Long KH, RubioO-Tapia A, Wagie AE, et al. The economics of celiac disease: a population-based study. Alimentary pharmacology & therapeutics. 2010; 32(2): 261-269.
[20]  HCUPnet. Healthcare Cost and Utilization Project (HCUP). 2014. Agency for Healthcare Research and Quality, Rockville, MD. Accessed May 5, 2017.
[21]  US Census Bureau. Population and housing unit estimates: Guidance for geographies users. Accessed May 5, 2017.
[22]  Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001; 120(3): 636–51.
[23]  Mohammadibakhsh R, Sohrabi R, Salemi M, Mirghaed MT, Behzadifar M. Celiac disease in Iran: a systematic review and meta-analysis. Electronic Physician. 2017; 9(3): 3883-3895.
[24]  Kolimarala V, Vasita E, Banoub H, Chong SKF. Seronegative Coeliac Disease in Children: A Case Report and Review of the Literature. Case Reports in Pediatrics. 2017; 2017: 1652052.
[25]  Bai D, Brar P, Holleran S, Ramakrishnan R, Green PH. Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men. Scand J Gastroenterol. 2005; 40: 183-7.
[26]  Bardella MT, Fredella C, Saladino V, Trovato C, Cesana BM, Quatrini M, Prampolini L. Gluten intolerance: gender- and age-related differences in symptoms. Scand J Gastroenterol. 2005; 40: 15-9.
[27]  Unalp-Arida A, Ruhl CE, Choung RS, Brantner TL, Murray JA. Lower Prevalence of Celiac Disease and Gluten-Related Disorders in Persons Living in Southern vs Northern Latitudes of the United States. Gastroenterology. 2017 Feb 24. pii: S0016-5085(17)30176-2.
[28]  Weiss AJ, Elixhauser A. Overview of Hospital Stays in the United States, 2012: Statistical Brief #180. 2014 Oct. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2006 Feb-. Available from